Cargando…

Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke

BACKGROUND: Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed to estimate the association between adipose tissue specific insulin resistance a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qi, Yan, Hongyi, Jin, Aoming, Meng, Xia, Lin, Jinxi, Li, Hao, Wang, Yongjun, Pan, Yuesong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693091/
https://www.ncbi.nlm.nih.gov/pubmed/38041145
http://dx.doi.org/10.1186/s13098-023-01235-2
_version_ 1785153083053965312
author Zhou, Qi
Yan, Hongyi
Jin, Aoming
Meng, Xia
Lin, Jinxi
Li, Hao
Wang, Yongjun
Pan, Yuesong
author_facet Zhou, Qi
Yan, Hongyi
Jin, Aoming
Meng, Xia
Lin, Jinxi
Li, Hao
Wang, Yongjun
Pan, Yuesong
author_sort Zhou, Qi
collection PubMed
description BACKGROUND: Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed to estimate the association between adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke. METHODS: Patients with ischemic stroke without a history of diabetes mellitus in the Third China National Stroke Registry were included. Adipose tissue specific insulin resistance index (Adipo-IR) was calculated by fasting serum insulin and free fatty acids and categorized into 5 groups according to the quintiles. Outcomes included stroke recurrence (ischemic or hemorrhagic), combined vascular events, all-cause death, and poor outcome (modified Rankin Scale, 3–6) at 12 months after stroke onset. We assessed the association between Adipo-IR and risk of prognosis by multivariable Cox/logistic regression models adjusted for potential covariates. RESULTS: Among 2,222 patients, 69.0% were men with a mean age of 62.5 years. At 12 months, 185 (8.3%) patients had recurrent stroke, 193 (8.7%) had combined vascular events, 58 (2.6%) died, and 250 (11.5%) had a poor outcome. Compared with patients with the lowest quintile, patients with the second, third, fourth, fifth quintiles of the Adipo-IR were associated with an increased risk of stroke recurrence (hazard ratio [HR], 1.77; 95% CI, 1.04–3.03; P = 0.04; HR, 2.19; 95% CI, 1.30–3.68; P = 0.003; HR, 1.84; 95% CI, 1.06–3.21; P = 0.03; HR, 2.11; 95% CI, 1.20–3.71; P = 0.01, respectively) and marginally associated with an increased risk of combined vascular events ( HR, 1.60; 95%CI, 0.97–2.64; P = 0.07; HR, 1.91; 95% CI, 1.17–3.13; P = 0.01; HR, 1.62; 95% CI, 0.96–2.75; P = 0.07; HR, 1.80; 95% CI, 1.05–3.09; P = 0.03, respectively) at 12 months after adjustment for potential covariates. Adipo-IR was not associated with mortality and poor outcome at 12 months. CONCLUSIONS: These findings suggest that adipose tissue specific insulin resistance is independently associated with recurrent stroke and combined vascular events after acute ischemic stroke in nondiabetic patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01235-2.
format Online
Article
Text
id pubmed-10693091
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106930912023-12-03 Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke Zhou, Qi Yan, Hongyi Jin, Aoming Meng, Xia Lin, Jinxi Li, Hao Wang, Yongjun Pan, Yuesong Diabetol Metab Syndr Research BACKGROUND: Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed to estimate the association between adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke. METHODS: Patients with ischemic stroke without a history of diabetes mellitus in the Third China National Stroke Registry were included. Adipose tissue specific insulin resistance index (Adipo-IR) was calculated by fasting serum insulin and free fatty acids and categorized into 5 groups according to the quintiles. Outcomes included stroke recurrence (ischemic or hemorrhagic), combined vascular events, all-cause death, and poor outcome (modified Rankin Scale, 3–6) at 12 months after stroke onset. We assessed the association between Adipo-IR and risk of prognosis by multivariable Cox/logistic regression models adjusted for potential covariates. RESULTS: Among 2,222 patients, 69.0% were men with a mean age of 62.5 years. At 12 months, 185 (8.3%) patients had recurrent stroke, 193 (8.7%) had combined vascular events, 58 (2.6%) died, and 250 (11.5%) had a poor outcome. Compared with patients with the lowest quintile, patients with the second, third, fourth, fifth quintiles of the Adipo-IR were associated with an increased risk of stroke recurrence (hazard ratio [HR], 1.77; 95% CI, 1.04–3.03; P = 0.04; HR, 2.19; 95% CI, 1.30–3.68; P = 0.003; HR, 1.84; 95% CI, 1.06–3.21; P = 0.03; HR, 2.11; 95% CI, 1.20–3.71; P = 0.01, respectively) and marginally associated with an increased risk of combined vascular events ( HR, 1.60; 95%CI, 0.97–2.64; P = 0.07; HR, 1.91; 95% CI, 1.17–3.13; P = 0.01; HR, 1.62; 95% CI, 0.96–2.75; P = 0.07; HR, 1.80; 95% CI, 1.05–3.09; P = 0.03, respectively) at 12 months after adjustment for potential covariates. Adipo-IR was not associated with mortality and poor outcome at 12 months. CONCLUSIONS: These findings suggest that adipose tissue specific insulin resistance is independently associated with recurrent stroke and combined vascular events after acute ischemic stroke in nondiabetic patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01235-2. BioMed Central 2023-12-02 /pmc/articles/PMC10693091/ /pubmed/38041145 http://dx.doi.org/10.1186/s13098-023-01235-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhou, Qi
Yan, Hongyi
Jin, Aoming
Meng, Xia
Lin, Jinxi
Li, Hao
Wang, Yongjun
Pan, Yuesong
Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_full Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_fullStr Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_full_unstemmed Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_short Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_sort adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693091/
https://www.ncbi.nlm.nih.gov/pubmed/38041145
http://dx.doi.org/10.1186/s13098-023-01235-2
work_keys_str_mv AT zhouqi adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT yanhongyi adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT jinaoming adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT mengxia adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT linjinxi adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT lihao adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT wangyongjun adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT panyuesong adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke